Myths vs facts: Pharmakogenetik Medicheck and stress

Pharmacogenetics (e.g., Medicheck) analyzes genetic variants that affect drug metabolism and response. A common myth is that such tests can also predict stress resilience or susceptibility. In reality, there are no validated genetic markers directly linked to subjective stress perception or coping. The provided context contains no evidence for such a connection—neither from GWAS nor clinical studies. Stress is a complex phenotype shaped by environment, lifestyle, psychosocial factors, and epigenetic changes. A consumer DNA test cannot reliably assess stress. Even related areas like cortisol regulation (see context on cortisol and weight gain) emphasize that home tests capture only a single time point and are not diagnostic. Conclusion: pharmacogenetic tests are useful for medication optimization, not stress analysis. To understand stress, validated questionnaires, clinical biomarkers (e.g., diurnal cortisol), and medical consultation are recommended. The evidence for direct genetic stress prediction is currently 'unclear' to 'marketing'.